Shares of Pure Bioscience, Inc. (OTCMKTS:PURE) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.35 and traded as high as $0.26. Pure Bioscience shares last traded at $0.23, with a volume of 67,585 shares.
The firm’s 50 day simple moving average is $0.28 and its 200 day simple moving average is $0.35.
In related news, Director Dale Okuno purchased 862,068 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The shares were acquired at an average price of $0.29 per share, for a total transaction of $249,999.72. 44.18% of the stock is owned by insiders.
About Pure Bioscience (OTCMKTS:PURE)
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. It manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection and formulates with other compounds.
Further Reading: How Investors Use a Balance Sheet
Receive News & Ratings for Pure Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pure Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.